Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07760038
Recruiting
Protective Mechanisms of Phycocyanin in Partial Hepatectomy-Associated Liver Injury
Not applicable · China · 1 site
Registry update: 12 Aug 2026
NCT07622316
Recruiting
GAIP ASD Research Study
Phase 1 · United States · 1 site
Registry update: 3 Jun 2026
NCT07455578
Recruiting
Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease
Phase 1 · Australia · 2 sites
Registry update: 1 Jun 2026
NCT07598383
Recruiting
A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic Dermatitis
Phase 2 · China · 1 site
Registry update: 7 Jul 2026
NCT06594939
Recruiting
Mosunetuzumab and Polatuzumab Vedotin With Split-Dose CHP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma
Phase 2 · United States · 1 site
Registry update: 25 Aug 2026
NCT07492823
Recruiting
Clinical Applicability of Liquid Biopsy in Chondrosarcoma
Not applicable · Austria · 1 site
Registry update: 7 Oct 2026
NCT07663253
Recruiting
Isatuximab-VRd in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients
Not applicable · China · 13 sites
Registry update: 23 Jun 2026
NCT07672860
Recruiting
Perioperative Ursodeoxycholic Acid for Renal Protection in Adults Undergoing Partial Nephrectomy for Renal Tumors
Phase 2 · China · 1 site
Registry update: 15 Oct 2026
NCT07671378
Recruiting
A Study of MRD-Guided Zanubrutinib Plus Sonrotoclax in Treatment-Naïve, High-Risk CLL/SLL Patients
Phase 2 · China · 1 site
Registry update: 26 Jun 2026
NCT07745244
Recruiting
Evaluation of the Accuracy and Safety of a Continuous Glucose Monitoring System
Not applicable · China · 1 site
Registry update: 4 Aug 2026
NCT07833748
Recruiting
Integrated Motor-Cognitive Training in Parkinson's Disease: A Feasibility Study
Not applicable · Italy · 1 site
Registry update: 22 Sept 2026
NCT07610720
Recruiting
Dalpiciclib, Anti-HER2 Therapy, and Endocrine Therapy for Hormone-Receptor-Positive, HER2-Positive Metastatic Breast Cancer
Phase 2 · China · 1 site
Registry update: 28 May 2026
NCT07635758
Recruiting
Human Placenta-derived 3D Mesenchymal Stem Cells(Guojianqingke)
Phase 1/2 · China · 1 site
Registry update: 9 Jun 2026
NCT07595107
Recruiting
Concordance Between Large Language Model and Multidisciplinary Team Recommendations in Rectal Cancer
Not applicable · China · 1 site
Registry update: 15 Oct 2026
NCT07381751
Recruiting
Artificial Intelligence-assisted MDS-UPDRS Assessment for Parkinson's Disease
Not applicable · China, Hong Kong · 2 sites
Registry update: 8 Jul 2026
NCT07560111
Recruiting
A Phase II Study of GC101 in NSCLC
Phase 2 · China · 1 site
Registry update: 5 Aug 2026
NCT07726680
Recruiting
GlycoQuest: An AI-Adaptive CGM-Integrated Serious Game for Pediatric Type 1 Diabetes
Not applicable · Pakistan · 1 site
Registry update: 24 Jul 2026
NCT07636798
Recruiting
Hepatic Arterial Infusion Chemotherapy Plus Envafolimab and Lenvatinib for First-Line Unresectable Advanced Biliary Tract Cancer
Phase 1/2 · China · 1 site
Registry update: 13 Jul 2026
NCT07779486
Recruiting
High- vs Standard-Dose Intravenous Magnesium for Acute Headache
Not applicable · Tunisia · 1 site
Registry update: 21 Aug 2026
NCT07619885
Recruiting
The Pharmacokinetics and Pharmacodynamics Study of Evategrel CG-0255 Besylate）and Plavix® in Healthy Participants
Phase 1 · United States · 1 site
Registry update: 29 Jun 2026

Ordered by registry start date. Freshness and sponsorship never change the order.